EP3265127
MIFEPRISTONE AND OCTREOTIDE FOR USE IN THE TREATMENT OF CUSHING'S SYNDROME IN A PATIENT HAVING AN ADRENOCORTICOTROPIC HORMONE (ACTH)-SECRETING PANCREATIC NEUROENDOCRINE TUMOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.2.2016EP published:
21.2.2024EP application number:
16759295.5
EPO information:
European Patent Register
Max expiry date:
24.2.2036
Title in English:
MIFEPRISTONE AND OCTREOTIDE FOR USE IN THE TREATMENT OF CUSHING'S SYNDROME IN A PATIENT HAVING AN ADRENOCORTICOTROPIC HORMONE (ACTH)-SECRETING PANCREATIC NEUROENDOCRINE TUMORLanguage of the patent:
English
Timeline
Today
25.2.2016EP application
21.2.2024EP Publication
Owner
Name:
Corcept Therapeutics, Inc.Address:
149 Commonwealth Drive, Menlo Park CA 94025, US
Inventor
Name:
MORAITIS, Andreas G.Address:
Menlo Park, California 94025, US
Name:
BELANOFF, Joseph K.Address:
Menlo Park, California 94025, US
Priority
Number:
201562127153 PDate:
2.3.2015Country:
US
Classification
Categories:
A61K 45/06, C07D 413/06, A61P 35/00, A61K 38/06, A61K 38/12, A61K 51/08, A61K 31/437, A61K 31/4745, A61K 31/505, A61K 31/513, A61K 31/567, A61P 3/10, A61K 38/08